Aim of the Study: Incidence of ureterolithiasis in pediatric population is increasing in recent years. Recently medical treatment of distal ureteral stones with doxazosin has advantages to have patients stone free within a shorter period, less stay in hospitals and causing cost saving.

Methods: Between 2015-2017 total 46 Patients with ureteral stones analyzed. 38 were eligible for the study to the exclusion criterias. Complete data were available for all patients. Their age range was 1-17 years (mean 8,3 years ). Patients were divided into 2 main groups: group 1 (n =17), who received doxazosin once daily, before bed; and group 2 (n =21), who had ureterenoscopy, uretherolitotripsy. All patients had distal ureteral stone. Datas were abstracted using manual chart review. Passage was defined as radiographic clearance .

Main Results: Mean expulsion times for groups 1 and 2 were 13,1 and 29,8 days(p<0,005), avarege hospitalization days for group 1 was 2,7 days and fort group 2 was 8,04 days (p<0,005). And the mean cost for groups 1 and 2 were 863,9 – 2009,7 Turkish Liras (p<0,005). In group 1, 2 of the patients underwent surgery (11%) and 1 patient had urinary tract infection(5,8%). In group 2, 1 patient had urinoma after surgery and 3 of patients had urinary tract infection(9,5%).

Conclusions: As it is discussed in many studies alpha blockers are shown to be a safe and effective therapy option for ureteral stones in pediatric patients. Use of alpha blockers have advantages in stone free preiod, shortened hospitalizations and lower cost.